USA flag logo/image

An Official Website of the United States Government

LIPID INCORPORATED SERUM-FREE MEDIUM

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
2889
Program Year/Program:
1987 / SBIR
Agency Tracking Number:
2889
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Oncology Laboratorytory, In
771 Main Street West Warwick, RI 02893
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 1987
Title: LIPID INCORPORATED SERUM-FREE MEDIUM
Agency: HHS
Contract: N/A
Award Amount: $221,000.00
 

Abstract:

THE LONG-TERM OBJECTIVE OF THIS PROJECT IS TO DESIGN A SERUM-FREE CHEMICALLY DEFINED MEDIUM FOR OPTIMUM GROWTH OF MAMMALIAN CELLS IN VITRO. THE SPECIFIC AIM OF THIS PROPOSAL IS TO SOLUBILIZE, BY MEANS OTHER THAN THE USE OF CARRIER PROTEINS, FATTY ACIDS, ALPHA-LIPOIC ACID, FAT-SOLUBLE VITAMINS, AND CHOLESTEROL IN AN EXISTENT SERUM-FREE MEDIUM, CHEE'S ESSENTIAL MEDIUM (CEM). BESIDES HORMONES, GROWTH AND ATTACHMENT FACTORS, LIPIDS MAY BE IMPORTANT SUBSTANCES FOR OPTIMUM GROWTH AND PRODUCTION OF END PRODUCTS BY MAMMALIAN CELLS IN VITRO. IT IS EXPECTED THAT, DURING PHASE I STUDIES, METHODS WILL BE DEVELOPED TO INCORPORATE FATTY ACIDS, FAT-SOLUBLE VITAMINS, ALPHA-LIPOIC ACID, AND CHOLESTEROL INTO CEM WITHOUT THE USE OF CARRIER PROTEINS. PHASE II STUDIES WILL FOCUS ON FURTHER IMPROVEMENT OF CEM BY INCORPORATING ORGANIC AND WATER-SOLUBLE HORMONES AND GROWTH FACTORS INTO CEM. A SERUM-FREE CEM THAT WILL OPTIMIZE THE GROWTH OF CELLS IN VITRO WOULD FIND WIDE APPLICATION IN RESEARCH AND BIOTECHNOLOGY LABORATORIES. THE COMMERCIAL VALUE OF SUCH A PRODUCT WOULD BE SIGNIFICANT.

Principal Investigator:

Darwin O. Chee
Principal Investigator
4018285250

Business Contact:

Small Business Information at Submission:

Oncology Laboratorytory, In
771 Main Street West Warwick, RI 02893

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No